A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension

Status:
Terminated

Trial end date:
2010-07-01

Target enrollment:

Participant gender:

Study will assess PF-00489791 efficacy and safety in Pulmonary Arterial Hypertension (PAH)

Phase 2

Pfizer

Sildenafil Citrate